Go to top of page

Warning message

There is currently a suspension or adjustment to some of our activities due to COVID-19. For full details please visit our Activities in response to COVID-19 information page.

ARPANSA activities in response to COVID-19

17 March 2020

Updated 22 May 2020

As a Federal Government Agency working under the Department of Health, ARPANSA is committed to supporting the health and safety of all Australians. During this period, as the Government works to protect the community from the effects of the novel coronavirus (COVID-19), we are working to support our staff and all stakeholders as we do our part to reduce the spread.

For up-to-date information and advice on COVID-19, please refer to the Department of Health website.  

Our offices in Sydney (Miranda) and Melbourne (Yallambie) are currently closed to the public, with a small number of staff working on site. ARPANSA is now implementing a staged return to on-site work and recommencement of some suspended or adjusted services in a COVID Safe workplace.

Many services that were altered or suspended during earlier stages of our response to COVID-19 have now recommenced, however, some activities continue to be impacted as follows:

  • Regulatory activities are continuing, with the exception that remote inspections have increased and some on-site inspections have been postponed.
  • Our Talk to a Scientist program continues to be available via email and our website contact form. However, phone support remains unavailable until further notice.   
  • Audit schedules and processes for our Australian Clinical Dosimetry Service (ACDS) have been adjusted with increased focus on remote auditing. Staff are continuing to work closely with hospitals to prioritise urgent requests for audits of radiotherapy machines.
  • Hire of radiation meters will remain unavailable until further notice.

All other laboratories and services that were altered or temporarily unavailable during the earlier period of our response are now operational.

Other activities, including our Comprehensive Test Ban Treaty radionuclide monitoring system, medical permits, UV monitoring network and other radiation monitoring programs continue to operate as normal.

We will provide further updates to this advice as required.